Related Experiment Video
Updated: Jun 24, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Candidate biomarkers for Parkinson's disease
Ali Khodadadian1, Mohsen Hemmati-Dinarvand2, Ashkan Kalantary-Charvadeh2
1Department of Medical Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Summary
Parkinson's disease (PD) diagnosis needs better biomarkers. Research reviews potential biomarkers like alpha-synuclein, microRNAs, and peptoids for early detection of PD and early onset PD (EOPD).
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Parkinson's disease (PD) is a common neurodegenerative disorder affecting over 65s.
- Neuropathology involves substantia nigra neuron loss, dopamine deficiency, and alpha-synuclein aggregates.
- Early onset PD (EOPD) is a familial form with unclear molecular differences from late onset PD (LOPD).
Purpose of the Study:
- To review potential biomarkers for early diagnosis of Parkinson's disease.
- To explore molecules beyond alpha-synuclein, including microRNAs and peptoids.
Main Methods:
- Literature review of studies on PD biomarkers.
- Analysis of various biological molecules and detection techniques.
Main Results:
- Alpha-synuclein is a primary focus for PD biomarker research.
- MicroRNAs and peptoids are emerging as other potential biomarkers.
- Current research highlights the need for improved diagnostic tools.
Conclusions:
- Identifying reliable biomarkers is crucial for early PD diagnosis and management.
- Further research into molecules like microRNAs and peptoids is warranted.
- Distinguishing EOPD from LOPD requires deeper molecular understanding.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...